nedaplatin has been researched along with Nasopharyngeal Carcinoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Hou, T; Hu, C; Jiang, S; Liu, X; Ma, J; Zhang, H; Zhang, N; Zou, W | 1 |
| Bai, YH; Du, KP; He, F; Li, JF; Liu, H; Liu, R; Lu, ZQ; Shi, QY; Tao, HY; Wang, ZL; Zhang, JJ | 1 |
| Liang, X; Liu, Q; Yang, S; Yao, W | 1 |
| Bei, JX; Chen, DN; Chen, QY; Guo, L; Guo, SS; Hao, WW; Li, Y; Li, YX; Liu, LT; Liu, R; Mai, HQ; Mo, HY; Peng, JY; Qian, CN; Sun, SY; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Yuan, L; Zeng, MS | 1 |
| Blanchard, P; Tao, Y | 1 |
| Huang, J; Li, Q; Liao, W; Wang, X; Wen, F; Wu, Q; Zhang, N; Zhang, P; Zhu, G | 1 |
| Chen, M; Gu, J; Guo, W; He, X; Jiang, X; Wang, D; Wang, X; Wu, J; Xu, L; Ye, J; Yin, L; Zhang, J; Zong, D | 1 |
| Fan, J; Ju, D; Li, L; Lin, C; Liu, J; Liu, Z; Nie, D; Tao, Q; Wu, J; Zhao, S | 1 |
| Bian, XH; Chen, M; Gu, JJ; Guo, WJ; He, X; Jiang, XS; Qian, PD; Wang, X; Wu, J; Wu, JF; Xu, JH; Yin, L; Zhang, YW; Zhu, HF | 1 |
| Cheng, ZB; Liao, H; Lin, Z; Liu, YM; Lv, BJ; Peng, PJ; Tang, C; Wang, SY; Wang, ZH | 1 |
| Cheng, Z; Feng, S; Fidelis, C; Kuang, Y; Li, F; Liang, Z; Lin, Z; Ullah, S; Wang, S; Yang, Y | 1 |
| Lan, XW; OuYang, PY; Su, Z; Tang, J; Xiao, Y; Xie, FY; Zou, XB | 1 |
| Feng, B; Fu, JT; Hu, Y; Shi, D; Shi, Z | 1 |
3 trial(s) available for nedaplatin and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.
Topics: Adult; Autocrine Communication; Cell Line, Tumor; Chemokine CCL2; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Progression-Free Survival; Radiation Tolerance; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2020 |
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Drug Design; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Young Adult | 2015 |
Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Patient Compliance; Prospective Studies; Survival Rate | 2016 |
10 other study(ies) available for nedaplatin and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome | 2022 |
Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Retrospective Studies; Thrombocytopenia | 2022 |
Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?
Topics: Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Platinum; Salts | 2018 |
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; China; Cisplatin; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Markov Chains; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2019 |
Radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of Epstein-Barr virus infection.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Epstein-Barr Virus Infections; G2 Phase Cell Cycle Checkpoints; Herpesvirus 4, Human; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Radiation Tolerance; Radiation-Sensitizing Agents | 2014 |
Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Autophagy; Butadienes; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Macrolides; Microtubule-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitriles; Organoplatinum Compounds; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.
Topics: Adult; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Survivors | 2015 |
Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome | 2016 |
Clinical efficacy and safety of gemcitabine plus nedaplatin in the treatment of advanced nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Case-Control Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Treatment Outcome | 2016 |